Earlier this year, messagingLAB was named II❤NYCSmall Business Thank You 100. This was awarded to 100 New York City small businesses that stayed open and thrived during the pandemic.

Last week I mentioned, I've been obsessing over generic drug manufacturing.

This isn't an out-of-the-blue Karl Schmieder obsession. I've worked on communications projects for biopharma manufacturers and, for about a decade, have written about quality control issues associated with foreign manufacturers.

Two weeks ago, during one of SynBioBeta's Townhalls, synthetic biology pioneer Drew Endy reminded us to define the future.

I have to admit, I'd been writing a newsletter based on Rita Gunter McGrath's book SEEING AROUND CORNERS. McGrath is one of my favorite business strategist. Her work is practical and highly actionable.

My piece involved some sci-fi systems thinking and speculation about our post COVID-19 world. Ultimately I was unsatisfied with the draft, So, I put it aside and decided to write something else. 

You would probably guess that it's easy to tell a story when times are good. The biggest challenge then is that everyone else is telling a good story. When there's a crisis and the world's been turned upside down, that's when leaders and their stories matter most. Here's why:

At Messaginglab, we value communications and connections.

I started this company to help life sciences companies better communicate with their audiences. The 2020 COVID-19 pandemic feels like one of those times when stories are more important than ever.

As the COVID-19 pandemic unfolds, I want to take a moment to share a few thoughts and updates on what I am doing to serve you and my clients.

Everything is different. A month ago, I was helping plan an April 30th consumer biotechnology conference. Two weeks ago, my co-organizers and I were discussing whether or not we should cancel the conference because of COVID19 news. Seven days ago, the pandemic was declared. New York City asked us to stay home. The U.S. declared a national emergency.